PERSPECTA

News from every angle

← Back to headlines

MannKind Advances Clinical Trials for Inhaled IPF Therapy

MannKind (MNKD) is advancing its clinical trials for an inhaled therapy targeting Idiopathic Pulmonary Fibrosis (IPF).

5 Jun, 21:56 — 5 Jun, 21:56
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual72d ago

MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy

Read full article →

Related Stories

Dutch Sports Car Manufacturer Spyker Returns with New Model

13m ago

Virgin Secures Track Access for Eurostar Rival Launch in 2030

20m ago

Aston Martin Invests $2 Million in Survival Strategy

42m ago

Norway Wealth Fund and ECB Warn of AI-Driven Stock Market Bubble

43m ago